Onyx Pharmaceuticals
Biopharmaceutical company committed to improving the lives of people with cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD14.3b (Public information from Aug 2013)
South San Francisco California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Seed | ||
$20.0m | Late VC | ||
$10.5b Valuation: $10.5b | Acquisition | ||
| Total Funding | CAD27.3m | ||